Symbols / ATXI $0.56 +0.00% Avenue Therapeutics, Inc.
ATXI Chart
Stock Fundamentals
|
|
|
|
|
|
About
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain. It also develops BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
Ratings
Current target
$0.56
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2023-12-11 | init | Maxim Group | — → Buy | $1 |
| 2023-04-03 | init | Aegis Capital | — → Buy | $32 |
- Avenue (OTC: ATXI): Axsome to acquire Baergic; up to $82M milestones, royalties - Stock Titan hu, 06 Nov 2025 08
- Rare muscle disease drug deal: Avenue backs ATX-04 for Pompe - Stock Titan Mon, 23 Feb 2026 08
- Avenue Therapeutics (ATXI) Sells Baergic Bio to Axsome Therapeutics - GuruFocus hu, 06 Nov 2025 08
- Avenue Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com Sun, 29 Mar 2026 07
- Avenue Therapeutics Inc. (ATXI) reports earnings - qz.com Mon, 31 Mar 2025 07
- ATXI Stock Price and Chart — OTC:ATXI - TradingView Wed, 25 May 2022 07
- What is the current Price Target and Forecast for Avenue Therapeutics (ATXI) - Zacks Investment Research Sat, 06 May 2023 20
- ATXI Stock Earnings: Avenue Therapeutics Misses EPS for Q1 2024 - InvestorPlace Wed, 15 May 2024 07
- ATXI Stock Price, Quote & Chart | AVENUE THERAPEUTICS INC (NASDAQ:ATXI) - ChartMill Wed, 10 Jun 2020 21
- Lightning Alerts: SOUN, ATER, TMPO, and ATXI - RagingBull ue, 17 Jan 2023 08
- Avenue Therapeutics Earnings Estimates, EPS & Revenue | OTC:ATXI - Benzinga Sat, 31 Jul 2021 05
- Top movers in Monday's pre-market session - ChartMill Mon, 29 Apr 2024 07
- ARMISTICE CAPITAL, LLC Acquires Additional Shares in Avenue Ther - GuruFocus hu, 14 Nov 2024 08
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
1.40
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
1.40
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
4.69
-58.43%
|
11.28
-22.40%
|
14.54
+80.78%
|
8.04
|
| Research And Development |
|
1.04
-84.39%
|
6.64
-35.87%
|
10.36
+284.03%
|
2.70
|
| Selling General And Administration |
|
3.65
-21.24%
|
4.64
+10.98%
|
4.18
-21.81%
|
5.34
|
| General And Administrative Expense |
|
3.65
-21.24%
|
4.64
+10.98%
|
4.18
-21.81%
|
5.34
|
| Other Gand A |
|
3.65
-21.24%
|
4.64
+10.98%
|
4.18
-21.81%
|
5.34
|
| Total Expenses |
|
4.69
-58.43%
|
11.28
-22.40%
|
14.54
+80.78%
|
8.04
|
| Operating Income |
|
-3.29
+70.88%
|
-11.28
+22.40%
|
-14.54
-80.78%
|
-8.04
|
| Total Operating Income As Reported |
|
-3.08
+72.68%
|
-11.28
+22.40%
|
-14.54
-80.78%
|
-8.04
|
| EBITDA |
|
-3.29
+70.88%
|
-11.28
-11.10%
|
-10.16
-315.72%
|
-2.44
|
| Normalized EBITDA |
|
-3.50
+67.23%
|
-10.69
+25.81%
|
-14.41
-79.66%
|
-8.02
|
| EBIT |
|
-3.29
+70.88%
|
-11.28
-11.10%
|
-10.16
-315.72%
|
-2.44
|
| Total Unusual Items |
|
0.22
+137.01%
|
-0.59
-113.83%
|
4.26
-23.69%
|
5.58
|
| Total Unusual Items Excluding Goodwill |
|
0.22
+137.01%
|
-0.59
-113.83%
|
4.26
-23.69%
|
5.58
|
| Special Income Charges |
|
0.20
|
0.00
|
—
|
—
|
| Net Income |
|
-2.91
+75.03%
|
-11.65
-12.29%
|
-10.38
-192.15%
|
-3.55
|
| Pretax Income |
|
-2.95
+74.80%
|
-11.70
-11.52%
|
-10.49
-191.09%
|
-3.60
|
| Net Non Operating Interest Income Expense |
|
0.12
-31.25%
|
0.18
+185.44%
|
-0.21
+81.93%
|
-1.14
|
| Interest Expense Non Operating |
|
—
|
0.00
-100.00%
|
0.33
-71.38%
|
1.16
|
| Net Interest Income |
|
0.12
-31.25%
|
0.18
+185.44%
|
-0.21
+81.93%
|
-1.14
|
| Interest Expense |
|
—
|
0.00
-100.00%
|
0.33
-71.38%
|
1.16
|
| Interest Income Non Operating |
|
0.12
-31.25%
|
0.18
+39.68%
|
0.13
+530.00%
|
0.02
|
| Interest Income |
|
0.12
-31.25%
|
0.18
+39.68%
|
0.13
+530.00%
|
0.02
|
| Other Income Expense |
|
0.22
+137.01%
|
-0.59
-113.83%
|
4.26
-23.69%
|
5.58
|
| Gain On Sale Of Security |
|
0.01
+102.55%
|
-0.59
-113.83%
|
4.26
-23.69%
|
5.58
|
| Gain On Sale Of Business |
|
0.20
|
0.00
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-2.95
+74.80%
|
-11.70
-11.52%
|
-10.49
-191.09%
|
-3.60
|
| Net Income From Continuing Operation Net Minority Interest |
|
-2.91
+75.03%
|
-11.65
-12.29%
|
-10.38
-192.15%
|
-3.55
|
| Net Income From Continuing And Discontinued Operation |
|
-2.91
+75.03%
|
-11.65
-12.29%
|
-10.38
-192.15%
|
-3.55
|
| Net Income Continuous Operations |
|
-2.95
+74.80%
|
-11.70
-11.52%
|
-10.49
-191.09%
|
-3.60
|
| Minority Interests |
|
0.04
-13.64%
|
0.04
-60.36%
|
0.11
+117.65%
|
0.05
|
| Normalized Income |
|
-3.13
+71.73%
|
-11.06
+24.41%
|
-14.63
-60.26%
|
-9.13
|
| Net Income Common Stockholders |
|
-2.91
+75.03%
|
-11.65
-12.29%
|
-10.38
-192.15%
|
-3.55
|
| Diluted EPS |
|
-0.93
+94.11%
|
-15.79
+78.51%
|
-73.48
+39.89%
|
-122.25
|
| Basic EPS |
|
-0.93
+94.11%
|
-15.79
+78.51%
|
-73.48
+39.89%
|
-122.25
|
| Basic Average Shares |
|
3.13
+141.75%
|
1.30
+817.14%
|
0.14
+384.72%
|
0.03
|
| Diluted Average Shares |
|
3.13
+141.75%
|
1.30
+817.14%
|
0.14
+384.72%
|
0.03
|
| Diluted NI Availto Com Stockholders |
|
-2.91
+75.03%
|
-11.65
-12.29%
|
-10.38
-192.15%
|
-3.55
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
1.85
|
| Current Assets |
|
1.85
|
| Cash Cash Equivalents And Short Term Investments |
|
1.78
|
| Cash And Cash Equivalents |
|
1.78
|
| Receivables |
|
—
|
| Prepaid Assets |
|
—
|
| Other Current Assets |
|
0.07
|
| Total Non Current Assets |
|
0.00
|
| Total Liabilities Net Minority Interest |
|
1.20
|
| Current Liabilities |
|
1.20
|
| Payables And Accrued Expenses |
|
0.60
|
| Payables |
|
0.40
|
| Accounts Payable |
|
0.08
|
| Current Accrued Expenses |
|
0.20
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.01
|
| Other Current Liabilities |
|
0.59
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
|
| Stockholders Equity |
|
1.58
|
| Common Stock Equity |
|
1.58
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
0.34
|
| Ordinary Shares Number |
|
0.34
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
92.51
|
| Retained Earnings |
|
-90.93
|
| Minority Interest |
|
-0.93
|
| Total Equity Gross Minority Interest |
|
0.65
|
| Total Capitalization |
|
1.58
|
| Working Capital |
|
0.65
|
| Invested Capital |
|
1.58
|
| Net Tangible Assets |
|
1.58
|
| Tangible Book Value |
|
1.58
|
| Duefrom Related Parties Current |
|
—
|
| Dueto Related Parties Current |
|
0.32
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-1.83
+79.69%
|
-9.03
+4.50%
|
-9.45
-24.42%
|
-7.60
|
| Cash Flow From Continuing Operating Activities |
|
-1.83
+79.69%
|
-9.03
+4.50%
|
-9.45
-24.42%
|
-7.60
|
| Net Income From Continuing Operations |
|
-2.95
+74.80%
|
-11.70
-11.52%
|
-10.49
-191.09%
|
-3.60
|
| Other Non Cash Items |
|
0.17
-74.77%
|
0.67
-85.77%
|
4.68
+782.83%
|
0.53
|
| Stock Based Compensation |
|
0.67
-46.20%
|
1.24
+36.42%
|
0.91
+39.60%
|
0.65
|
| Operating Gains Losses |
|
-0.02
-103.23%
|
0.59
+113.83%
|
-4.26
+23.69%
|
-5.58
|
| Gain Loss On Investment Securities |
|
-0.02
-103.23%
|
0.59
+113.83%
|
-4.26
+23.69%
|
-5.58
|
| Change In Working Capital |
|
0.30
+67.60%
|
0.18
+161.72%
|
-0.29
-171.08%
|
0.41
|
| Change In Receivables |
|
—
|
—
|
0.00
-100.00%
|
0.09
|
| Change In Prepaid Assets |
|
0.00
+118.18%
|
-0.01
-115.71%
|
0.07
+333.33%
|
-0.03
|
| Change In Payables And Accrued Expense |
|
0.30
+56.84%
|
0.19
+152.78%
|
-0.36
-203.45%
|
0.35
|
| Investing Cash Flow |
|
—
|
0.00
+100.00%
|
-3.00
|
0.00
|
| Cash Flow From Continuing Investing Activities |
|
—
|
0.00
+100.00%
|
-3.00
|
0.00
|
| Capital Expenditure |
|
—
|
—
|
-3.00
|
—
|
| Net Intangibles Purchase And Sale |
|
—
|
0.00
+100.00%
|
-3.00
|
0.00
|
| Purchase Of Intangibles |
|
—
|
0.00
+100.00%
|
-3.00
|
0.00
|
| Financing Cash Flow |
|
2.09
-78.71%
|
9.84
+30.71%
|
7.53
-28.60%
|
10.54
|
| Cash Flow From Continuing Financing Activities |
|
2.09
-78.71%
|
9.84
+30.71%
|
7.53
-28.60%
|
10.54
|
| Net Common Stock Issuance |
|
2.09
+29.02%
|
1.62
-78.43%
|
7.53
-27.60%
|
10.39
|
| Common Stock Payments |
|
—
|
—
|
0.00
+100.00%
|
-1.10
|
| Repurchase Of Capital Stock |
|
—
|
—
|
0.00
+100.00%
|
-1.10
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
9.42
+942000.00%
|
0.00
-99.32%
|
0.15
|
| Net Other Financing Charges |
|
—
|
-1.21
|
—
|
-0.51
|
| Changes In Cash |
|
0.26
-67.82%
|
0.81
+116.47%
|
-4.92
-267.23%
|
2.94
|
| Beginning Cash Position |
|
2.59
+45.49%
|
1.78
-73.42%
|
6.71
+78.26%
|
3.76
|
| End Cash Position |
|
2.85
+10.06%
|
2.59
+45.49%
|
1.78
-73.42%
|
6.71
|
| Free Cash Flow |
|
-1.83
+79.69%
|
-9.03
+27.51%
|
-12.45
-63.92%
|
-7.60
|
| Common Stock Issuance |
|
2.09
+29.02%
|
1.62
-78.43%
|
7.53
-34.55%
|
11.50
|
| Issuance Of Capital Stock |
|
2.09
+29.02%
|
1.62
-78.43%
|
7.53
-34.55%
|
11.50
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-K2026-03-30 View
- 8-K2026-02-23 View
- 42026-01-06 View
- 8-K2025-12-31 View
- 8-K2025-11-18 View
- 10-Q2025-11-13 View
- 8-K2025-11-12 View
- 10-Q2025-08-14 View
- 10-Q2025-05-15 View
- 8-K2025-04-30 View
- 42025-04-02 View
- 10-K2025-03-31 View
- 8-K2025-03-17 View
- 8-K2025-03-07 View
- 42024-12-03 View
- 8-K2024-11-29 View
- 10-Q2024-11-14 View
- 8-K2024-11-14 View
- 42024-11-07 View
- 42024-10-01 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|